Recent Updates
Recently added Catalysts
BSX

Boston Scientific to Participate in Piper Jaffray Health Care Conference Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference on December 1 in New York City. Ray ...

Key Takeaway: NATICK, Mass. , Nov. 22, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Piper Jaffray Health Care Conference on December 1 in New York City . Ray Elliott , President and Chief Executive Officer, and Jeff Capello , Exe

Full Press Release Details

NATICK, Mass. , Nov. 22, 2010 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Piper Jaffray Health Care Conference on December 1 in New York City .
Ray Elliott , President and Chief Executive Officer, and Jeff Capello , Executive Vice President and Chief Financial Officer, will participate in a 30-minute discussion about the Company beginning at approximately 8:30 a.m. ET .
A live webcast of this discussion will be available to all interested parties on Boston Scientific's website at www.bostonscientific.com . Please visit the website for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.
This webcast is being hosted by Thomson Reuters. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com beginning approximately one hour following the completion of the discussion.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com .
CONTACT: Paul Donovan
508-650-8541 (office)
508-667-5165 (mobile)
Media Relations
Boston Scientific Corporation
Larry Neumann
508-650-8696 (office)
Investor Relations
Boston Scientific Corporation
Sean Wirtjes
508-652-5305 (office)
Investor Relations
Boston Scientific Corporation
SOURCE Boston Scientific Corporation

21 %

Last updated: Nov 22, 2010